Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -78.01% is 26% above its 4-year average of -105.58%, near the high end of its 4-year range (-324.43%–-16.75%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.45% below its 12-month average of -66.99%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -78.01%.
RETURN ON INVESTED CAPITAL (ROIC)
-78.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-66.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-138.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-105.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-119.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.45%
CURRENT VS 3Y AVG
+43.71%
CURRENT VS 5Y AVG
+26.12%
CURRENT VS 10Y AVG
+34.50%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.92%
median of 494 covered companies
CURRENT VS SECTOR MEDIAN
-169.74%
vs the sector median at left
Bone Biologics Corporation
Market Cap
$897948.00
Return on Invested Capital (ROIC)
-78.01%
TTM Avg
-66.99%
3Y Avg
-138.57%
5Y Avg
-105.58%
Market Cap
$893920.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-416.12%
3Y Avg
-338.16%
5Y Avg
-243.59%
Market Cap
$877747.00
Return on Invested Capital (ROIC)
-343.55%
TTM Avg
-272.49%
3Y Avg
-270.70%
5Y Avg
-191.72%
Market Cap
$815044.00
Return on Invested Capital (ROIC)
-77.55%
TTM Avg
-118.09%
3Y Avg
-161.88%
5Y Avg
-137.96%
Market Cap
$1.01M
Return on Invested Capital (ROIC)
-59.81%
TTM Avg
-3.58%
3Y Avg
-5.96%
5Y Avg
-5.96%
Market Cap
$693655.00
Return on Invested Capital (ROIC)
4.47%
TTM Avg
-1129.41%
3Y Avg
-780.32%
5Y Avg
-986.52%
Market Cap
$1.09M
Return on Invested Capital (ROIC)
-60.41%
TTM Avg
-162.02%
3Y Avg
-321.37%
5Y Avg
-223.75%
Market Cap
$1.13M
Return on Invested Capital (ROIC)
-9.45%
TTM Avg
-4.19%
3Y Avg
5.39%
5Y Avg
5.39%
Market Cap
$1.16M
Return on Invested Capital (ROIC)
-128.95%
TTM Avg
-69.60%
3Y Avg
-67.51%
5Y Avg
-50.89%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bone Biologics Corporation (BBLG) | $897948.00 | -78.01% | -66.99% | -138.57% | -105.58% |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A | -416.12% | -338.16% | -243.59% |
| Decoy Therapeutics Inc. (DCOY)vs › | $877747.00 | -343.55% | -272.49% | -270.70% | -191.72% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $815044.00 | -77.55% | -118.09% | -161.88% | -137.96% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | -59.81% | -3.58% | -5.96% | -5.96% |
| CDT Equity Inc. (CDT)vs › | $693655.00 | 4.47% | -1129.41% | -780.32% | -986.52% |
| Clearmind Medicine Inc. (CMND)vs › | $1.09M | -60.41% | -162.02% | -321.37% | -223.75% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.13M | -9.45% | -4.19% | 5.39% | 5.39% |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | -128.95% | -69.60% | -67.51% | -50.89% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.15M | -709.40% | -164.13% | -164.13% | -164.13% |
ROIC
-78.0%
ROE
-73.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -78.01% |
| 2026-03-31 | -64.27% |
| 2025-12-31 | -60.16% |
| 2025-09-30 | -67.43% |
| 2025-06-30 | -65.08% |
| 2025-03-31 | -149.58% |
| 2024-12-31 | -121.11% |
| 2024-09-30 | -100.84% |
| 2024-06-30 | -170.31% |
| 2024-03-31 | -195.50% |
| 2023-12-31 | -324.43% |
| 2023-09-30 | -251.98% |
| 2023-06-30 | -152.75% |
| 2023-03-31 | -220.93% |
| 2022-12-31 | -61.65% |
| 2022-09-30 | -64.45% |
| 2022-06-30 | -33.06% |
| 2022-03-31 | -26.66% |
| 2021-12-31 | -16.75% |
| 2018-12-31 | -694.63% |
| 2018-09-30 | -156.84% |
| 2016-12-31 | -2658.99% |
| 2016-06-30 | -6490.07% |
| 2016-03-31 | -761.71% |
| 2015-09-30 | -159.96% |
| 2015-06-30 | -90.48% |
| 2014-04-30 | -1284808.62% |
